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Abstract. 
 
Peripherin, a type III intermediate ﬁlament 
(IF) protein, upregulated by injury and inﬂammatory 
cytokines, is a component of IF inclusion bodies associ-
ated with degenerating motor neurons in sporadic
amyotrophic lateral sclerosis (ALS). We report here 
that sustained overexpression of wild-type peripherin 
in mice provokes massive and selective degeneration of 
motor axons during aging. Remarkably, the onset of
peripherin-mediated disease was precipitated by a deﬁ-
ciency of neuroﬁlament light (NF-L) protein, a phe-
nomenon associated with sporadic ALS. In NF-L null 
mice, the overexpression of peripherin led to early-
onset formation of IF inclusions and to the selective 
death of spinal motor neurons at 6 mo of age. We also 
report the formation of similar peripherin inclusions in 
presymptomatic transgenic mice expressing a mutant 
form of superoxide dismutase linked to ALS. Taken to-
gether, these results suggest that IF inclusions contain-
ing peripherin may play a contributory role in motor 
neuron disease.
Key words: peripherin • neuroﬁlament • ALS • mo-
tor neuron • transgenic
 
A
 
MYOTROPHIC
 
 lateral sclerosis (ALS)
 
1
 
 is an adult-onset
neurological disorder that affects primarily motor
neurons in the brain and spinal cord. The degener-
ation of motor neurons leads to atrophy of skeletal mus-
cles and, ultimately, to paralysis and death. Approximately
10% of the ALS cases are familial with the disease inher-
ited in an autosomal dominant manner. Mutations in the
copper/zinc superoxide dismutase (SOD1) gene have been
found in 
 
z
 
20% of familial cases (2% of total ALS cases)
(Rosen et al., 1993). Whereas transgenic mouse studies
provided compelling evidence that SOD1 mutations cause
ALS through a gain of deleterious activities (Gurney et al.,
1994; Wong et al., 1995; Ripps et al., 1995; Tu et al., 1996;
Bruijn et al., 1997, 1998), the etiology of ALS remains un-
known for the vast majority of sporadic and familial cases.
One hallmark of ALS is the presence of cytoplasmic inclu-
sions of disorganized proteins in the cytoplasm of motor
neurons (reviewed in Chou, 1995). Some inclusions have
been shown to contain mutant SOD1 protein (Kato et al.,
1996; Shibata et al., 1996; Bruijn et al., 1998), whereas oth-
ers contain neuronal intermediate filament (IF) proteins
(Carpenter, 1968; Tu et al., 1996).
Peripherin is a type III neuronal IF protein of 57 kD
which is found with neurofilament (NF) proteins in the
majority of IF inclusions (89%) in motor neurons of ALS
patients (Corbo and Hays, 1992; Migheli et al., 1993; Tu et
al., 1996). In adults, peripherin is mostly expressed in auto-
nomic nerves and in peripheral sensory neurons with only
low levels detectable in spinal motor neurons (Parysek
and Goldman, 1988; Brody et al., 1989; Escurat et al., 1990;
Troy et al., 1990a,b). However, peripherin gene expression
is increased by up to 300% in spinal motor neurons after
injury of the sciatic nerve (Troy et al., 1990a), whereas ex-
pression of all three NF subunits mRNAs is reduced
(Muma et al., 1990). Inflammation is one mechanism that
can explain the upregulation of peripherin in injured neu-
rons. In fact, peripherin gene expression is upregulated by
the inflammatory cytokines interleukin-6 (IL-6) and leu-
kemia inhibitory factor (LIF; Djabali et al., 1993; Sterneck
et al., 1996) through the action of a JAK/STAT signaling
pathway activating the STAT 1 and STAT 3 transcription
factors (Lecomte et al., 1998). The action of cytokines on
peripherin expression suggests that an upregulation of pe-
ripherin may be part of a general response of motor neu-
rons to noxious stress that may explain the presence of nu-
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Abbreviations used in this paper:
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LIF, leukemia inhibitory factor; NF, neurofilament; NF-H, neurofilament
heavy subunit; NF-L, neurofilament light subunit; NF-M, neurofilament
medium subunit; SOD1, copper/zinc superoxide dismutase; WT, wild-
type. 
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merous peripherin inclusion bodies in motor neurons of
ALS patients.
In contrast to NFs, which are obligate heteropolymers of
three subunits (Ching and Liem, 1993; Lee et al., 1993),
peripherin can self-assemble to establish an IF network in
cultured cells (Cui et al., 1995; Ho et al., 1995; Beaulieu et
al., 1999). Peripherin can also interact in vivo with NF pro-
teins (Parysek et al., 1991) and can form heterodimers
with each one of the three NF subunits in vitro (Athlan
and Mushynski, 1997). We have recently studied the inter-
actions of peripherin with NF proteins in cultured SW13
cells devoid of endogenous cytoplasmic IF proteins (Beau-
lieu et al., 1999). Our results showed that peripherin can
assemble with NFs as well as with the light NF subunit
(NF-L) protein alone to form an IF network. Unexpect-
edly, the expression of peripherin with the heavy NF sub-
units (NF-H or NF-M) in the absence of NF-L prevented
the formation of an IF network in transfected cells (Beau-
lieu et al., 1999).
We have used a transgenic mouse approach to investi-
gate the potential detrimental effects of a sustained pe-
ripherin overexpression in motor neurons. Our results
show that an upregulation of peripherin in mice causes a
late-onset and selective motor neuron disease character-
ized by the formation of IF inclusions similar to those
found in human ALS and in mice expressing mutant form
of SOD1 linked to ALS. Moreover, the formation of IF in-
clusion bodies and the onset of disease were precipitated
by a deficiency in NF-L protein probably through a delete-
rious action of the large NF subunits on peripherin organi-
zation.
 
Materials and Methods
 
Transgenic and Knockout Mice
 
The DNA constructs used to produce mice expressing the mouse periph-
erin gene under the control of the human Thy-1 gene promoter were de-
rived as followed. The Thy-1 regulatory sequences were isolated by long
range PCR amplification (XL PCR™ system; Perkin Elmer) from a vector
(pBSV; a gift of Dr. Vincent Giguère, McGill University, Montreal) con-
taining the complete human Thy-1 gene (GenBank/EMBL/DDBJ acces-
sion number M11749) (van Rijs et al., 1985). The 5
 
9
 
 primer (TGCCCGC-
CTGATGAATGCTCATCCGGAATTC) corresponded to the vector
sequence upstream from the Thy-1 locus in pBSV. The 3
 
9
 
 primer
(GGATCCAGGACTGAGATCCCAGAACC) was complementary to
the last 26 bp from the noncoding fraction of the second exon of the hu-
man Thy-1 gene. Both primers were purchased from GIBCO-BRL. The
resulting 3.5-kb PCR product was digested with EcoRI to remove the
pBSV sequence of the 5
 
9
 
 primer before its insertion in pBluescript SK
 
1
 
(Stratagene) in the EcoRI to EcoRV orientation. The resulting vector in-
cluded the promoter, the first exon, the first intron, and the complete 5
 
9
 
noncoding region of the second exon of the human Thy-1 gene subcloned
upstream of an HindIII site in the multicloning cassette of pBluescript
SK
 
1
 
. A 5.9-kb peripherin fragment was then obtained by the Eco47III,
EcoRV digestion of a bacteriophage clone containing the complete mouse
peripherin locus (a gift from Dr. André Royal, Université de Montréal,
Montréal). This fragment was subcloned into the HindIII site of the Thy-1
vector. The correct orientation of the peripherin fragment was confirmed
by XhoI and ApaI digestion. The resulting construct (TPer) included the
human Thy-1 gene regulatory sequences followed by the complete coding
sequence of the mouse peripherin gene starting at 23 bp upstream of the
putative translation start site (Cui et al., 1995; Ho et al., 1995) and ending
2.5 kb downstream of the polyadenylation signal (see Fig. 1 A).
The 9.5-kb DNA fragment (Per), used to derive mice expressing the
mouse peripherin gene under the control of its own promoter element,
was obtained by digestion of the original bacteriophage DNA with
EcoRV. The Per fragment contained the complete peripherin gene along
 
with 3.1 kb from the 5
 
9
 
 and 2.5 kb from the 3
 
9
 
 flanking genomic sequences
(see Fig. 1 A).
The constructs were isolated from their vector sequences by digestion
with endonuclease restriction enzymes followed by purification on aga-
rose gels using a Gene Clean II Kit™ (Bio101). The resulting linear DNA
fragments were microinjected into one-cell mouse embryos of C57Bl/C3H
genetic background according to standard procedures (Brinster et al.,
1981). The integration of the transgenes into mouse genomic DNA was
confirmed by Southern blot analysis as described below.
Mice carrying the transgenes in NF-L null background were obtained
by breeding transgenic mice with NF-L knockout mice (L
 
2/2
 
 mice) (Zhu
et al., 1997). The breeding was performed following a two-step procedure.
In the first step, F1 transgenic mice were bred with NF-L knockout mice
to generate mice carrying the transgene in an L
 
1
 
/
 
2
 
 background. These
mice were then backcrossed with L
 
2/2
 
 mice leading to the production of
mice carrying the transgene in L
 
2/2
 
 background. All peripherin trans-
genic mice used in this study were heterozygous for the peripherin trans-
genes.
The SOD1
 
G37R
 
 mice (Wong et al., 1995) were a kind gift of Drs. Donald
L. Price (Johns Hopkins Medical School, Baltimore, MD) and Don Cleve-
land (Ludwig Institute, San Diego, CA).
 
Southern Blot Analysis
 
Southern blot analysis of genomic DNA isolated from mouse tails was car-
ried out following procedures described previously (Côté et al., 1993). A
1.8-kb peripherin probe was generated by digestion of the Per DNA con-
struct with EcoRI (see Fig. 1 A). This probe was designed for detection of
a 1.8-kb band corresponding to the endogenous peripherin gene while the
TPer transgene was detected as a 4.9-kb band. The probe and enzymatic
digestion protocols used to detect the NF-L knockout genotype have been
described previously (Zhu et al., 1997). The number of transgene copies
inserted in the genome was estimated by Southern blotting with serial di-
lution of DNA extracted from F1 transgenic and nontransgenic mice from
each line. The relative intensity of the bands was compared with the signal
detected for the endogenous peripherin gene using Gel-pro 2.0.1 (Media
Cybernetic) with a Power Macintosh computer.
 
Northern Blot Analysis
 
6-mo-old animals were killed by injection of an overdose of chloral hy-
drate. Tissues were collected, frozen in liquid nitrogen, and kept at 
 
2
 
80
 
8
 
C
before extraction of total RNA using the Trizol reagent™ (GIBCO-
BRL). Total RNA (10 
 
m
 
g except 5 
 
m
 
g for dorsal root ganglia) were frac-
tionated on 1% (wt/vol) agarose-formaldehyde gels, transferred to Gene
screen plus™ membranes (NEN Life Science), hybridized, and washed ac-
cording to standard procedures (Sambrook et al., 1989). The mRNA spe-
cies were detected by autoradiography using Biomax MR™ film (Kodak)
in the presence of an intensifying screen.
The actin probe corresponded to the complete cDNA from the rat
 
b
 
-actin. The peripherin probe corresponded to the first 538 bp of the periph-
erin transcript (GenBank/EMBL/DDBJ accession number X59840). This
probe was derived by PCR from mouse genomic DNA using the (AT-
GAGCCATCATCACTCGTCGGGCC) 5
 
9
 
 primer and the (TCTGCT-
TGAGCGCCGCTAGGTCCT) 3
 
9
 
 primer. The NF-L probe was derived
by PCR of the mouse NF-L first exon (GenBank/EMBL/DDBJ accession
number M20480) using the (ATGAGTTCGTTCGGCTCGGATCC-
GAT) 5
 
9
 
 primer and the (CCTCATAGCGAGCCTGCAGGTTGCG) 3
 
9
 
primer. The primers used to derive these two probes were purchased from
GIBCO-BRL and the PCR reactions were carried out using Taq poly-
merase (Pharmacia). All probes were purified on agarose gels and labeled
using the random primer method before hybridization (Feinberg and Vo-
gelstein, 1983).
 
Antibodies
 
The anti-peripherin monoclonal antibody (MAB1527), the anti-periph-
erin polyclonal antibody (AB1530), and the anti 
 
a
 
-internexin polyclonal
antibody (AB1515) were from Chemicon. The anti-peripherin mono-
clonal antibody (NCL-Periph) was from Novocastra Laboratories Ltd.
The anti–NF-H polyclonal antibody (N-4142) is from Sigma. The anti–NF-M
monoclonal antibody (NN-18), the anti–NF-L monoclonal antibody (NR-4),
the anti-hyperphosphorylated NF-H monoclonal antibody (RT-97), and
the anti-actin clone c4 monoclonal antibody were from Boehringer Mann-
heim. The anti-hypophosphorylated NF-H monoclonal antibody (Smi-32)
was from Steinberger Monoclonal Inc. 
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SDS-PAGE and Western Blot Analysis
 
6–10-mo-old mice (except if otherwise mentioned in figure legend) were
killed and the tissues collected as for Northern blot analysis. For total pro-
tein extraction, tissues were homogenized in 0.5% (wt/vol) SDS, and 8 M
urea (SDS/urea buffer). Preparation of the cytoskeletal insoluble proteins
was carried out using a modified version of the method described by
Ching and Liem (1993). Tissues were first homogenized at 48
 
8
 
C in a buffer
containing Tris (10 mM), NaCl (150 mM), EDTA (1 mM), Triton X-100
(1% wt/vol), PMSF (2 mM), leupeptin (2 mg/ml), pepstatin (1 mg/ml),
and aprotinin (10 mg/ml). The homogenates were then centrifuged at
14,000 
 
g
 
 for 15 min at 4
 
8
 
C using a Sorvall MC-12V centrifugator (Dupont).
The supernatants (soluble fraction) were collected and kept for further
use. The pellets (insoluble fraction) were resuspended in a volume of
SDS/urea buffer equivalent to the volume of the soluble fraction. The pro-
tein concentration in the different extracts was measured using the DC-
Protein assay™, (BioRad). The protein extracts were diluted in 2
 
3
 
 sam-
ple buffer (30% [wt/vol] glycerol, 4% [wt/vol] SDS, 160 mM Tris HCl [pH
6.8], 10% [vol/vol] 
 
b
 
-mercaptoethanol and 0.02% [wt/vol] bromophenol
blue) and boiled for 3 min. Proteins were separated on 8% or 10% SDS-
PAGE and either transferred to a nitrocellulose membrane or stained
with 0.2% (wt/vol) Coomassie blue-R250 in a 10% (vol/vol) acetic acid
and 45% (vol/vol) methanol solution. Nitrocellulose membranes were
blocked in PBS containing 5% (wt/vol) skimmed milk powder (PBS/milk)
before incubation with the primary antibodies diluted as follows:
MAB1527, NR-4, and NN-18, 1:1,000 dilution; AB1515 and N-4142, 1:2,000;
anti-actin, 1:5,000. After incubation, the blots were rinsed in PBS contain-
ing 0.1% (wt/vol) of Tween-20 (PBS/Tween) and incubated for 1 h with
the appropriate secondary antibody (anti–mouse IgG peroxidase or anti–
rabbit IgG peroxidase from the Jackson ImmunoResearch Laboratories)
diluted 1:1,000 in PBS/milk. The immune complexes were revealed using
the RenaissanceÙ chemiluminescence reagents (NEN Life Science).
 
Immunohistological Analysis
 
Immunohistochemical analysis was carried out as described by Jacomy
and Bosler (1995). Mice were anesthetized by injection of chloral hydrate
and perfused with a 16-g/liter sodium cacodylate buffer (pH 7.5) followed
by fixative (3% [vol/vol] glutaraldehyde in sodium cacodylate buffer). 50-
 
m
 
m tissue sections were prepared using a vibratome. Floating sections
were rinsed in PBS and treated for 30 min with a 1% (wt/vol) sodium
borohydride solution to reduce epitope masking by glutaraldehyde. Sec-
tions were then blocked for 1 h in a PBS solution containing 3% (wt/vol)
BSA, 0.5% (vol/vol) Triton X-100, and 0.03% (wt/vol) hydrogen perox-
ide. Incubation with the various antibodies was performed overnight at
room temperature with agitation in a PBS solution containing 3% (wt/vol)
BSA and 0.05% (vol/vol) Triton X-100. The antibody labeling was devel-
oped using a Vector ABC kit (Vector Laboratories Ltd.) and Sigmafast™
tablets (Sigma).
For indirect double immunofluorescence analysis, mice were perfused
with PBS (pH 7.5) followed by fixative (4% vol/vol paraformaldehyde in a
phosphate buffered solution). Tissues were postfixed for 2 h in paraform-
aldehyde, rinsed in PBS, and incubated overnight in a 20% (wt/vol) phos-
phate-buffered sucrose solution. 20-
 
m
 
m tissue sections were prepared us-
ing a cryostat. Sections were then blocked for 30 min in a PBS solution
containing 3% (wt/vol) BSA and 0.5% (vol/vol) Triton X-100. Incubation
with mixtures of primary antibodies was performed overnight at room
temperature in a PBS solution containing 3% (wt/vol) BSA and 0.05%
(wt/vol) Triton X-100. Incubation with a mixture of the anti–mouse-FITC
and anti–rabbit rhodamine-conjugated antibody (Jackson ImmunoRe-
search Laboratory) was carried out for one hour under the same condi-
tions. The samples were finally mounted in Prolong™ (Molecular Probe,
Inc.) and examined with a fluorescence microscope.
 
Morphology and Electron Microscopy
 
Tissue sections were prepared for embedding in Epon as described in
Zhu et al. (1997). Thin sections were stained with Toluidine blue and ex-
amined under a light microscope. The counting of axons in the L5 ventral
root was performed manually from photographs. For electron microscopy,
ultrathin sections were stained with a lead citrate solution and examined
with a Philips CM10 transmission electron microscope.
To evaluate the survival of spinal motor neurons, a portion of the spinal
cord spanning 1-mm rostral to 1-mm caudal of the L5 ventral root entry
point was dissected out from two 14-mo-old mice of each genotype. The
spinal cord was then cut in 50-
 
m
 
m sections using a vibratome and stained
with cresyl violet according to standard procedures (Bancroft and Stevens,
1990). The large motor neurons in the ventral horn were then counted
with the help of a technician who ignored the genotypes of the mice. Since
this method did not produce an equal number of sections from each sam-
ple, the mean number of motor neurons per ventral horn section was cal-
culated and compared for each genotype.
 
Motor Dysfunction
 
To evaluate motor dysfunction in the mice, we simply measured their ca-
pacity to grasp a vertical grid. The mice were placed at the center of a hor-
izontal grid. The grid was then moved slowly to a vertical position. The
time spent by the mice on the vertical grid was measured for a maximum
of 2 min. This test was performed using five mice of each genotype and
was repeated three times on separate days for a total of 15 tests per geno-
type.
 
Results
 
Generation of Transgenic Mice Overexpressing the 
Wild-Type Mouse Peripherin Gene
 
Two different DNA constructs were microinjected to gen-
erate transgenic mice overexpressing the wild-type mouse
peripherin gene in motor neurons. The first DNA con-
struct, called TPer, included the promoter of the Thy-1
gene with noncoding sequences of exon 1 and 2 (van Rijs
et al., 1985) fused to the mouse peripherin gene starting at
23 nucleotides upstream from the initiation codon (Fig. 1
A). The second DNA construct, called Per, consisted of
the complete mouse peripherin gene with 3.4 kb of 5
 
9
 
 and
2.5 kb of 3
 
9
 
 untranslated sequences (Fig. 1 A).
Six founders were obtained for each DNA construct.
After Northern blot analysis of nervous tissues, we fo-
cused our efforts on the characterization of two lines of
transgenic mice, the TPer line carrying 4 integrated copies
of the TPer construct, and the Per line bearing 20 copies of
the Per construct (Fig. 1 B).
Northern blot analysis was carried out to study the ex-
pression pattern of peripherin mRNA in normal and
transgenic mice. Peripherin mRNA was detected in dorsal
root ganglia (DRG) of normal (WT) mice, TPer trans-
genic mice, and Per transgenic mice (Fig. 1 C). Peripherin
mRNA was also detected in the brain but not in the cere-
bellum of the TPer mice (Fig. 1 C). No peripherin mRNA
was detected in nonnervous tissues of transgenic mice
(Fig. 1 C). A combination of immunohistochemistry and
Western blot analysis using anti-peripherin monoclonal
antibodies was carried out to further analyze the periph-
erin expression patterns in the transgenic lines. Our analy-
sis of normal mice allowed the detection of peripherin in
DRG, spinal cord, and some sensory fibers of the brain
stem. The TPer line showed a larger expression pattern
with the detection of peripherin in the brain, in the optic
nerve, in some reticular neurons of the brainstem, in the
mesencephalic trigeminal nucleus, in the motor nucleus of
the trigeminal and facial nerves, in the nucleus ambiguous,
in the ventral and dorsal columns of the spinal cord, in spi-
nal motor neurons, and in DRG. The Per mice overex-
pressed peripherin in sensory and motor neurons from the
spinal cord and brain stem but they did not express detect-
able levels of peripherin in the brain.
Densitometry of Western blots, made up by the serial
dilution of total protein extracts from dorsal and ventral
roots (Fig. 1 D), showed that as compared with WT mice 
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the peripherin levels were increased by approximately four-
fold in the ventral roots of TPer mice, approximately sev-
enfold in the ventral roots of Per mice, approximately two-
fold in dorsal roots of TPer mice, and approximately
threefold in dorsal roots of Per mice. An analysis of cy-
toskeletal Triton-insoluble extracts from the brain and
ventral roots revealed a recovery of peripherin in the in-
soluble fraction (Fig. 1 E). Densitometry of Coomassie
blue–stained SDS-PAGE of Triton-insoluble extracts was
further carried out to compare the peripherin levels to
those of NF-L in ventral and dorsal root axons (Fig. 1 F
and Table I). The identification of the bands correspond-
ing to NF-M, NF-L, and peripherin was confirmed by
Western blot analysis (Fig. 1 F). The results indicated that
the levels of peripherin in ventral roots of transgenic mice
overexpressing peripherin remained inferior to NF-L pro-
tein levels (Table I).
 
Extra Peripherin Causes Loss of Ventral Root Axons 
Late in Life
 
The peripherin transgenic mice developed normally and
did not exhibit overt phenotypes and pathology until very
late in life. A small number of mice from the TPer and Per
lines were maintained for more than two years. After two
years, the mice from both TPer and Per lines started to de-
velop motor dysfunctions. Examination at microscopy and
counting of L5 ventral roots revealed the loss of 
 
z
 
35% of
motor axons in aged mice overexpressing peripherin when
compared with their WT littermates (Fig. 2 and Table II).
Note that axonal loss occurred predominantly in the ven-
tral roots and that DRG axons were essentially spared.
Unlike spinal motor neurons from WT mice (Fig. 2 C),
most spinal motor neurons from transgenic mice were
characterized by strong and diffuse peripherin immunore-
activity in their perikarya and neurites without evidence of
 
Figure 1.
 
Transgenic mice overexpressing WT peripherin.
 
 
 
(A)
Partial restriction map of the Per and TPer DNA constructs. An
Eco47III 
 
3
 
 EcoRV fragment of the mouse peripherin gene was
subcloned downstream of the human Thy-1 gene promoter.
Black boxes represent exons. The white box represents the 5
 
9
 
transcriptional regulatory elements of the Thy-1 gene. The poly-A
designates the polyadenylation signal of the peripherin gene. The
peripherin probe used for the Southern blot analysis is indicated.
(B) Southern blot analysis of genomic DNA extracted from the
tails of control mice (WT) and of mice bearing the Per
 
 
 
or TPer
transgenes. (C) Northern blot showing expression of peripherin
mRNA in different tissues of WT, TPer, and Per mice. (D) West-
ern blot analysis of total protein extracts showing the increased
peripherin levels in ventral and dorsal roots of TPer and Per
transgenic mice. (E) Western blot analysis of soluble and insolu-
ble protein extracts from the brain of WT and transgenic TPer
mice. Two micrograms of insoluble protein extracts and an equiv-
alent volume of soluble protein extracts were fractionated on
SDS-PAGE and the blot was incubated with a mixture of mono-
clonal antibodies directed against NF-M (M), NF-L (L), periph-
erin (P), and actin (A). (F) Coomassie blue–stained SDS-PAGE
 
of Triton X-100 insoluble fractions (20 
 
m
 
g) from the ventral
roots showing the ratio of the peripherin (57-kD band) to NF-L
(66-kD band) in WT and transgenic mouse extracts. R corre-
sponds to a track loaded with the Rainbow molecular mass
marker (GIBCO). The identity of the bands was confirmed by in-
cubating a Western blot (W) of another part of the same gel with
a mixture of antibodies against NF-M (M), NF-L (L), and periph-
erin (P).
 
Table I. Relative Protein Levels of Peripherin Compared with 
NF-L in Cytoskeletal Fractions of Dorsal and Ventral Roots
 
Tissues Genotype
Ratio of
peripherin to NF-L
 
Ventral root WT (
 
n
 
 
 
5
 
 5) 0.090 
 
6
 
 0.037
TPer (
 
n
 
 
 
5
 
 3) 0.650 
 
6
 
 0.092
Per (
 
n
 
 
 
5
 
 4) 0.870 
 
6
 
 0.130
Dorsal root WT (
 
n
 
 
 
5
 
 5) 0.316 
 
6
 
 0.164
TPer (
 
n
 
 
 
5
 
 3) 0.590 
 
6
 
 0.095
Per (
 
n
 
 
 
5
 
 4) 1.180 
 
6
 
 0.057
 
20 
 
m
 
m of Triton X-100–insoluble fractions were fractionated on SDS-PAGE and
stained with Coomassie blue. The OD corresponding to the peripherin and NF-L
bands were then evaluated by densitometry. Ratios were calculated by dividing the pe-
ripherin OD by the NF-L OD for each mice. Results are mean 
 
6
 
 SD. 
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perikaryal swellings (Fig. 2 D). However, some peripherin
inclusion bodies were observed in neurites especially in
aged mice (Fig. 2 D).
 
Peripherin Overexpression in NF-L Null Background
 
Because substantial declines in NF-L gene expression oc-
curs in ALS (Bergeron et al., 1994), we tested the effect of
reducing NF-L levels on the progression of the peripherin-
mediated disease. Mice of the TPer and Per lines were
bred with our L
 
2/2
 
 mice (Zhu et al., 1997) to obtain mice
expressing the peripherin transgenes in a context of NF-L
deficiency. The breeding resulted in the mendelian trans-
mission of the peripherin transgenes and of the L
 
2/2
 
 geno-
type.
Previous results obtained from cell culture studies and
from L
 
2/2
 
 mice (Beaulieu et al., 1999; Williamson et al.,
1998) suggested that the organization of peripherin might
be affected by the absence of NF-L. Western blot analysis
of spinal cord extracts from the L
 
2/2
 
, Per;L
 
2/2
 
, and
TPer;L
 
2/2
 
 mice revealed reduced levels of peripherin,
NF-H, and NF-M proteins as a consequence of NF-L defi-
ciency (Fig. 3 A). Declines in levels of peripherin were
also detected in the brain and optic nerve extracts from
TPer;L
 
2/2
 
 mice indicating that peripherin produced un-
der the control of the Thy-1 promoter was also affected by
the absence of NF-L (Fig. 3 A). Northern blot analysis of
RNA from the brain and DRG of mice with various geno-
types revealed that the NF-L disruption had no effects on
peripherin mRNA levels (Fig. 3 B).
Figure 2. Motor axon de-
generation and peripherin
inclusions in aged mice over-
expressing wild-type periph-
erin. (A and B) Toluidine
blue staining of thin sections
of L5 ventral root axons from
28-mo-old mouse littermates
of WT (A) or Per (B) geno-
types. (C and D) Immunohis-
tochemical detection of pe-
ripherin in the spinal cord
with a monoclonal antibody
(NCL-Periph 1:200 dilution).
No peripherin signal was de-
tected in motor neurons of
WT mice (C), whereas mo-
tor neurons of transgenic
mice exhibited a strong dif-
fuse labeling for peripherin in
their perikarya (black arrow-
head in D). Peripherin posi-
tive inclusions were also ob-
served in neurites of spinal
motor neurons (white arrow-
head in D). Bars: (B) 100 mm;
(D) 25 mm.
 
Table II. Number of Motor Axons in L5 Ventral Roots of Mice 
with Different Genotypes
 
Genotype Age Number of axons
Loss of
motor axons
 
mo %
 
WT (
 
n
 
 
 
5
 
 3) 6 1055 
 
6
 
 64 0
WT (
 
n
 
 
 
5
 
 2) 28 1069 
 
6
 
 76 0
L
 
2/2
 
 (
 
n
 
 
 
5
 
 3) 6 860 
 
6
 
 52 19
L
 
2/2
 
 (
 
n
 
 
 
5
 
 3) 20 918 
 
6
 
 40 14
Per (
 
n
 
 
 
5
 
 2) 6 1056 
 
6
 
 45 0
Per (
 
n
 
 
 
5
 
 2) 28  688 
 
6
 
 87 35
TPer (
 
n
 
 
 
5
 
 3) 6 1074 
 
6
 
 54 0
TPer (
 
n
 
 
 
5
 
 1) 28 684 35
Per;L
 
2/2
 
 (
 
n
 
 
 
5
 
 3) 6 567 
 
6
 
 190 46
TPer;L
 
2/2
 
 (
 
n
 
 
 
5
 
 2) 2 741 
 
6
 
 14 30
TPer;L
 
2/2
 
 (
 
n
 
 
 
5
 
 3) 6 563 
 
6
 
 140 47
TPer;L
 
2/2
 
 (
 
n
 
 
 
5
 
 3) 14 438 
 
6 27 59
Loss of motor axons represents the percentage of missing axons as compared to WT.
n represents the number of mice for each category. Results are mean 6 SD.The Journal of Cell Biology, Volume 147, 1999 536
In addition to NFs, CNS neurons express another type
IV IF protein called a-internexin (Pachter and Liem,
1985). We have therefore examined the levels of a-inter-
nexin to test whether the downregulation of peripherin in
NF-L null mice was due to a general destabilization of
neuronal IF proteins. In contrast to peripherin, the levels
of a-internexin were not affected by the absence of NF-L
in L2/2 and TPer;L2/2 mice as revealed by Western blot
analysis of optic nerve extracts (Fig. 3 C). Then we exam-
ined whether the peripherin levels in motor and sensory
neurons were equally affected by the absence of NF-L
(Fig. 3 D). Whereas peripherin was readily detected by
Western blot in ventral root extracts of normal mice, the
levels of peripherin and NF proteins were at exceedingly
low levels in mice of the NF-L null background. It is note-
worthy that the levels of peripherin were less affected by
the absence of NF-L in dorsal roots than in ventral roots
(Fig. 3 D). Electron microscopy of nondegenerating axons
from ventral roots of 6-mo-old mice from the Per;L2/2
and TPer;L2/2 genotypes revealed that the cytoskeletal
organization of these axons did not greatly differ from the
one of motor axons of L2/2 mice. In both cases there was
a scarcity of IF structures with an elevated density of mi-
crotubules when compared with ventral root axons from
mice of the WT and TPer genotypes (Fig. 4, A–D). In con-
trast to ventral root axons, small unmyelinated axons of
dorsal roots in L2/2 and TPer;L2/2 mice showed little or
no changes in the density of IF structures (Fig. 4, E–H).
This observation is compatible with our Western blot re-
sult (Fig. 3 D) and with a report indicating that some un-
myelinated sensory axons express peripherin in the ab-
sence of NFs (Goldstein et al., 1996).
NF-L Deficiency Accelerates
Peripherin-mediated Disease
Mice with the TPer;L2/2 and Per;L2/2 genotypes devel-
oped aberrant hind limb positions and a progressive loss of
hind limb mobility. This motor dysfunction was generally
not apparent before 8 mo of age and often started on one
side before spreading to the other side. In mice of both
genotypes that were allowed to live until 14 mo of age, the
progression of the phenotypes resulted in paralysis of the
digits and of the lower limb articulations (Fig. 5 A). This
phenotype prompted us to examine signs of dysfunction in
younger mice. Thus, we measured the ability of 6-mo-old
mice of different genotypes to grasp a vertical grid. This
simple test revealed that the average grasping time for the
TPer;L2/2 mice was reduced by 80% when compared
with mice with L2/2, TPer, or TPer;L1/2 genotypes
(Fig. 5 B).
Light microscopy of L5 dorsal roots from 6-mo-old ani-
mals showed no degenerating axons in L2/2, TPer;L2/2,
and Per;L2/2 mice (Fig. 6, A–C). In contrast, examina-
tion of the ventral roots revealed a massive degeneration
of axons in the TPer;L2/2 and Per;L2/2 mice (Fig. 6, G
and I) but not in the other types of mice that were exam-
ined at this age (Fig. 6, D, E, F, and H). Further examina-
tion of degenerating ventral roots by electron microscopy
revealed the presence of degenerating myelin, axonal
sproutings, and occasional axonal filamentous spheroids in
the ventral roots of 6-mo-old Per;L2/2 and TPer;L2/2
mice (Fig. 6, J and K).
To evaluate the degree of degeneration, we counted the
number of axons in the ventral roots of 6-mo-old mice of
Figure 3. Reduced peripherin levels in
absence of NF-L. (A) Western blot
analysis of total protein extracts from
the spinal cord, brain, and optic nerves
of normal and transgenic 6-mo-old
mice. The gels were loaded with 5 mg
of protein from the brain and optic
nerve or with 20 mg of protein from the
spinal cord. Blots were incubated with
a polyclonal antibody directed toward
NF-H (top) or with a cocktail of mono-
clonal antibodies against NF-M, NF-L,
peripherin, and actin (bottom). (B)
Northern blot analysis of peripherin
mRNA from the brain and DRG in the
presence and absence of NF-L. The
blots were hybridized with the periph-
erin probe, stripped, rehybridized with
the NF-L probe, stripped again, and re-
hybridized with the actin probe. (C)
Western blot analysis showing that
a-internexin levels are not reduced in
NF-L knockout mice. Duplicate gels
were transferred to nitrocellulose
membranes and incubated with either
the monoclonal antibody cocktail as
described above or with a polyclonal
antibody against a-internexin. (D)
Western blot of total protein extracts (5 mg) from ventral and dorsal roots of 4-mo-old mice showing that peripherin levels were less af-
fected in dorsal roots than in ventral roots by the absence of NF-L.Beaulieu et al. Motor Neuron Death Caused by Peripherin Inclusions 537
different genotypes. The results are shown in Table II. The
upregulation of peripherin alone did not affect the number
of motor axons at this age, whereas the L2/2 genotype
was associated with a loss of z16% of motor axons at both
6 and 20 mo of age. 6-mo-old mice overexpressing periph-
erin in NF-L null background exhibited declines of 45–
50% in the number of their motor axons. The progressive
nature of the overt phenotypes observed in TPer;L2/2
and Per;L2/2 mice prompted us to monitor the loss of
motor axons in mice of different age. Analysis of ventral
root axons in the TPer;L2/2 mice at 2, 6, and 14 mo of
age revealed a parallel increase of motor dysfunction and
loss of motor axons culminating in the loss of 59% of mo-
tor axons in paralyzed mice at 14 mo of age (Table II).
To examine whether the massive loss of motor axons
was accompanied by a corresponding death of neurons, we
counted the number of motor neurons in a spinal cord re-
gion spanning a 3-mm rostral to caudal region at the level
of L5 ventral roots. These counts were performed on
Nissl-stained sections (Fig. 7). Two mice from each geno-
type were used for the analysis. Since similar results were
obtained for the two mice of each genotype, the data were
pooled and the mean number of large motor neuron per
Figure 4. Peripherin does not substitute for NF-L. (A–D) Electron microscopy of large myelinated axons from the ventral root of WT
(A), L2/2 (B), TPer (C), and TPerL2/2 (D) mice. Note the increased number of microtubules (white arrows) and the scarcity of IF
structures (black arrows) in mice of L2/2 and TPer;L2/2 genotypes when compared with WT and TPer mice. (E–H) Electron micros-
copy of small unmyelinated axons from the dorsal root of either WT (E), L2/2 (F), TPer (G), or TPer;L2/2 (H) mice. Note that some
of the null NF-L axons did not develop a scarcity of IF (black arrows). Bars, 0.2 mm.
Figure 5. Motor dysfunction in NF-L null mice overexpressing
peripherin. (A) Abnormal hind limb posture in a 14-mo-old
TPer;L2/2 mouse. (B) 6-mo-old TPer;L2/2 mice have reduced
grasping ability to a vertical grid. The results presented in the
graphic are a mean from three separate tests performed on five
mice of each genotype. Error bars correspond to standard devia-
tions. **Indicates a significant difference from WT (P , 0.01) ac-
cording to a Student’s t test (unpaired, double tail).The Journal of Cell Biology, Volume 147, 1999 538
ventral horn was calculated (Table III). This analysis re-
vealed a dramatic reduction in the mean number of large
spinal motor neurons (64% neuronal loss) present in the
ventral horns of 14-mo-old TPer;L2/2 mice as compared
with normal, TPer, and L2/2 mice (Fig. 7 and Table III).
Moreover, the loss of motor neurons during aging of the
TPer;L2/2 mice was progressive since 5-mo-old mice
showed a lower degree of neuronal loss (Table III).
We then verified whether an increased abundance of pe-
ripherin inclusions was associated with the acceleration of
the peripherin-mediated disease in the absence of NF-L. A
very weak peripherin immunostaining was observed in spi-
nal motor axons of WT and L2/2 mouse using an anti-
peripherin monoclonal antibody (Fig. 8 A). In TPer and Per
transgenic mice having a wild-type NF-L background, a
generally diffused peripherin staining with the occasional
presence of peripherin inclusion bodies was observed in
spinal motor neurons (Figs. 8 B and 2 D). Peripherin inclu-
sions were more frequent in the proximal axons of motor
neurons of TPer;L1/2 and Per;L1/2 mice (Fig. 8 C). Fi-
nally, the spinal cord of the TPer;L2/2 and Per;L2/2
mice was characterized by the presence of abundant pe-
ripherin inclusions in the perikarya and axons of motor
neurons and by a general disappearance of diffuse periph-
erin staining (Fig. 8, D and E). Similar peripherin inclu-
sions were also observed in the motor nucleus of the facial
and trigeminal nerves, in the nucleus ambiguous, in large
DRG neurons, and in the mesencephalic trigeminal nu-
cleus of the TPer;L2/2 and Per;L2/2 mice (data not
shown). In the TPer;L2/2 mice, the peripherin inclusions
were detectable in spinal motor neurons of mice at 2, 6,
and 14 mo of age. In thin sections stained with Toluidine
Figure 6. Accelerated degenera-
tion of ventral root axons in mice
overexpressing peripherin in ab-
sence of NF-L. (A–C) Toluidine
blue staining of thin sections of L5
dorsal root axons from 6-mo-old
L2/2 (A), TPer;L2/2 (B), and
Per;L2/2 (C) did not reveal degen-
eration of sensory axons in these
mice. (D–H) No degeneration of
axons was detected in L5 ventral
roots of 6-mo-old WT (D), TPer
(F), and Per (H) mice. The roots
from 6-mo-old L2/2 mice (E) were
characterized by an atrophy of ax-
ons but did not contained degener-
ating axons. In contrast, massive de-
generation of axons was evident in
roots of 6-mo-old TPer;L2/2 (G)
and Per;L2/2 (I) mice. (J and K)
Electron microscopy of these same
roots revealed the presence of de-
generating axons (black arrow in J),
axonal sproutings (white arrows in J),
and axonal filamentous spheroids
(sph in K) in ventral roots of the
TPer;L2/2 (J), and Per;L2/2 (K)
mice. The black arrow in K points
to a mitochondria entrapped in
an axonal spheroid. Bars: (A–C)
25 mm; (D–I) 100 mm; (J) 5 mm; (K)
2 mm.Beaulieu et al. Motor Neuron Death Caused by Peripherin Inclusions 539
blue, the peripherin inclusions appeared as hyaline inclu-
sion bodies with sizes ranging from 2 to 30 mm in length
(Fig. 8 F). Multiple distinct inclusion bodies were often de-
tected within the same neuron. These inclusions never
filled completely the perikarya of motor neurons. At elec-
tron microscopy, the peripherin inclusions appeared as
disorganized accumulations of 10-nm filaments mingled
with various membranous residues (Fig. 8, G and H). In-
clusion bodies containing mitochondria were also fre-
quently observed (Fig. 8 H).
Detection of NF-M and NF-H in Peripherin Inclusions
Since cell culture studies indicated that the large NF sub-
units can have a destabilizing effect on the organization of
peripherin (Beaulieu et al., 1999), we examined whether
the NF-M or NF-H proteins were present in the peripherin
inclusion bodies. Double indirect immunofluorescence
was carried out on spinal cord sections from the TPer;L2/2
mice using a peripherin polyclonal antibody and differ-
ent monoclonal antibodies against NF-M or NF-H pro-
teins. All peripherin inclusions observed in these analysis
were immunoreactive for NF-M, as revealed by the NN-18
antibody (Fig. 8 I), and for dephosphorylated NF-H as re-
vealed by the SMI-32 antibody (Fig. 8 J). A majority of in-
clusions also contained hyperphosphorylated NF-H as re-
vealed by their immunoreactivity to the RT-97 antibody
(Fig. 8 K). In rare cases, motor neurons showed a diffuse
pattern of peripherin staining in their perikarya. One such
neuron was encountered in the course of a double labeling
experiment involving the anti–NF-M monoclonal anti-
body. It is noteworthy that this neuron, which lacked in-
clusion bodies, was also showing a really weak NF-M im-
munoreactivity (Fig. 8 L) suggesting that the formation of
peripherin aggregates in motor neurons requires the pres-
ence of the large NF subunits.
Early Detection of Peripherin Inclusions in Mice 
Bearing SOD1G37R
Taken together, our results and the previous reports that
peripherin is present in the majority of IF inclusions in
sporadic ALS cases (Corbo and Hays, 1992; Migheli et al.,
1993; Tu et al., 1996) suggest that peripherin may play a
contributory role in ALS pathogenesis. Further support
for this view came from our immunodetection of periph-
erin inclusions in spinal cord sections of paralyzed and pre-
symptomatic mice expressing a Glycine 37 to Arginine
mutant form of SOD1 (SOD1G37R) associated with familial
human ALS (Wong et al., 1995). This analysis was carried
out in two different lines of transgenic mice, lines 42 and
29, which are characterized by disease onset at z5 and
z11 mo, respectively. Staining of spinal cord sections from
normal mice did not show any peripherin inclusions but al-
lowed the detection of peripherin in axons from the dorsal
column and in some motor axons of the ventral horns (Fig.
9, A and E). In contrast, peripherin inclusion bodies were
observed in paralyzed mice from both SOD1G37R lines
(Fig. 9, B and D). Staining of sections from presymptom-
atic mice of line 29 revealed the presence of peripherin in-
clusions in 5-mo-old mice (Fig. 9 C). Similar inclusions
were also observed in one out of three mice studied at 3
mo of age, indicating that the formation of peripherin in-
clusions in motor axons occurs at an early stage of the dis-
ease. It is noteworthy that peripherin inclusions were also
detected in the dorsal column in paralyzed but not in pre-
symptomatic mice from both SOD1G37R lines (Fig. 9, F–H).
Discussion
The transgenic mouse models described here are the first
examples of extensive motor neuron death in mice caused
by an upregulation of a wild-type IF protein. There are
previous reports of neuronal death due to expression of IF
Figure 7. Cresyl violet staining of L5 spinal cords. Light micros-
copy of spinal cords from 14-mo-old WT, L2/2, TPer, and TPer;
L2/2 mice showed a marked loss of large motor neurons (ar-
rows) in TPer;L2/2 mice.
Table III. Number of Large Motor Neurons per Ventral Horn in 
L5 Spinal Cord Sections
Genotype Age
Mean number of
motor neurons
per ventral horn
Loss of
motor neurons
mo %
WT (n 5 103) 14 19.9 6 4.8 0
TPer (n 5 115) 14 21.4 6 5.1 0
L2/2 (n 5 110) 14 15.9 6 4.2 20
TPer;L2/2 (n 5 74) 5 11 6 3.8 45
TPer;L2/2 (n 5 148) 14 7.3 6 4.4 64
Loss of motor axons represents the percentage of missing axons as compared to WT.
n represents the number of ventral horn sections for each category. Results are
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transgenes (Lee et al., 1994; Tu et al., 1997; Ching et al.,
1999; Ma et al., 1999), but this is the first example of mas-
sive and selective motor neuron death due to high levels of
wild-type IF protein. Our results demonstrate that an up-
regulation of wild-type peripherin is sufficient to induce
selective motor neuron death during aging and that a defi-
ciency of NF-L is a factor that precipitates dramatically
the onset and progression of disease, probably through the
deleterious effects of NF-M and NF-H on peripherin orga-
nization. Moreover, the acceleration of disease correlated
with the frequency of IF inclusions containing peripherin
in spinal motor neurons.
Three independent studies have shown that peripherin
is present in a majority of IF inclusions in ALS patients
(Corbo and Hays, 1992; Migheli et al., 1993; Tu et al.,
1996). We have also detected similar inclusions in pre-
symptomatic mice expressing a mutant SOD1G37R linked to
familial ALS (Fig. 9). Such IF inclusions in ALS may occur
as a consequence of axonal transport defects (Zhang et al.,
1997; Williamson and Cleveland, 1999). Alternatively, the
results presented here and the intense immunoreactivity
of IF inclusions for peripherin in ALS make it plausible
that such inclusion bodies could originate from an upregu-
lation of peripherin occurring at the level of gene tran-
scription. Peripherin is normally expressed at low levels in
motor neurons (Troy et al., 1990a), but enhanced levels,
Figure 8. IF inclusions contain peripherin and NF proteins. (A–E) Immunohistochemical detection of peripherin in spinal cord samples
with a monoclonal antibody (NCL-Periph 1:200 dilution). (A) A very weak peripherin signal was detected in motor neurons (black ar-
rows in A) of NF-L2/2 mice. (B) In the TPer mice, diffuse peripherin labeling (black arrow) and some small inclusions (white arrow)
were detected in motor neurons. (C) The lack of 50% of NF-L in the TPer;L1/2 mice caused the formation of more frequent periph-
erin inclusions in motor neuron axons (black arrow). (D and E) The total absence of NF-L resulted in the disappearance of a diffuse pe-
ripherin staining and in the formation of numerous peripherin inclusions in the cell bodies and axons of spinal motor neurons (black ar-
rows) of TPer and Per mice. (F) Hyaline inclusion bodies (black arrow) in the cytoplasm of motor neurons detected by Toluidine blue
staining of thin sections of the spinal cord from TPer;L2/2 mice. N indicates the cell nucleus. (G and H) Electron microscopy of inclu-
sion bodies found in motor neurons of TPer;L2/2 (G) and PerL2/2 (H) mice. The inclusions are formed of 10-nm filaments that are
sequestering membranous material (black arrows in G) and mitochondria (H). (I–L) Double indirect immunofluorescence of motor
neurons from the spinal cord of TPer;L2/2 mice. A polyclonal anti-peripherin antibody (AB1530 1:1,000 dilution) in red and the vari-
ous monoclonal antibodies directed against NF-M (NN-18 1:100 dilution), dephosphorylated NF-H (SMI-32 1:500 dilution) or hyper-
phosphorylated NF-H (RT 97 1:500 dilution) in green reveal the colocalization of peripherin, NF-M (I) and NF-H (J and K) in the inclu-
sion bodies. A double immunofluorescence staining of one neuron showing a diffused peripherin staining (L) in absence of
immunoreactivity for NF-M. All results presented in this figure were obtained from 6–8-mo-old mice. Bars: (A–E) 100 mm; (F) 110 mm;
(G) 1 mm; (H) 0.4 mm; (I–L) 15 mm.Beaulieu et al. Motor Neuron Death Caused by Peripherin Inclusions 541
and perhaps IF inclusion formation, could be part of a re-
generative response observed in ALS. It is well established
that after nerve injury the levels of peripherin mRNA are
induced by three- to fourfold in motor neurons (Troy et
al., 1990a). Other genes associated with the regenerative
response after neuronal injury, such as GAP43 and a1-
tubulin, have been reported to be upregulated in ALS
(Parhad et al., 1992). Moreover, peripherin is upregulated
by cytokines such as IL-6 and LIF (Djabali et al., 1993;
Sterneck et al., 1996). There is growing evidence for an in-
volvement of inflammatory reactions in ALS that could
account for enhanced levels of peripherin. A recent study
has indicated an increase of IL-6 in the cerebrospinal fluid
of ALS patient (Sekizawa et al., 1998). Moreover, an up-
regulation of LIF has been reported in an in vivo model of
glutamate excitotoxicity (Kurek et al., 1998), which is an-
other hypothesized mechanism of toxicity associated with
ALS (Lin et al., 1998). Finally, inflammatory cytokines are
associated with astrogliosis, which is a common phenome-
non in ALS and in other neurodegenerative diseases
(Klein et al., 1997).
Our previous cell culture studies with peripherin and NF
cDNA clones in SW13 cells demonstrated that peripherin
can self-assemble to form an IF network and that it assem-
bles with the NF network in the presence of NF-L (Beau-
lieu et al., 1999). However, in absence of NF-L, the NF-M
and NF-H proteins interact with peripherin to form disor-
ganized IF structures (Beaulieu et al., 1999). Perhaps, this
could explain why the peripherin-mediated disease was
exacerbated in the NF-L null background. The increased
number of IF inclusion bodies in mice deficient for NF-L is
probably due to abnormal interactions of peripherin and
the high molecular mass NF subunits. In this regard, it is
noteworthy that rare motor neurons in TPer;L2/2 mice
that were devoid of NF-M protein did not develop IF in-
clusions bodies even though peripherin was detected at el-
evated levels (Fig. 8 L). Similarly, small sensory neurons
that express peripherin but are devoid of NFs (Ferri et al.,
1990; Goldstein et al., 1996) maintained a normal IF net-
work in the NF-L null background (Fig. 4).
The NF-L null background mimics in part the depletion
in NF-L mRNA levels occurring in motor neurons of ALS
Figure 9. Peripherin inclu-
sions in SOD1G37R mice. Im-
munohistochemical labeling
with a peripherin polyclonal
antibody (AB1530 1:1,000 di-
lution) revealed the presence
of peripherin-containing in-
clusions in motor axons of
mice expressing the mutant
SOD1G37R, at early stage (ar-
rowheads in C), and end
stage of disease (arrowheads
in B and D). Staining from
spinal cord sections of nor-
mal mice yielded a weak
staining for peripherin in
ventral horn axons (arrow-
head in A) and dorsal column
axons (E) but no peripherin
inclusions were detected.
Note the detection of periph-
erin inclusions in the dorsal
column at end stage of dis-
ease in mice from line 42 and
line 29 (arrowhead in F and
H). Bars: (A–D) 75 mm;
(E–H) 50 mm.The Journal of Cell Biology, Volume 147, 1999 542
patients. In situ hybridization studies revealed a striking
60% reduction of NF-L mRNA levels in the a-motor neu-
rons of ALS patients as compared with age-matched con-
trols (Bergeron et al., 1994). Moreover, greater declines in
NF-L mRNA levels (87%) were detected in motor neu-
rons having spheroids or perikaryal filamentous accumula-
tions (Bergeron et al., 1994). Remarkably, our data dem-
onstrate that a partial depletion in NF-L levels is sufficient
to increase the abundance of peripherin inclusions. A 50%
reduction of NF-L mRNA in the TPer;L1/2 and Per;L1/2
mice resulted in the formation of peripherin inclusions in
proximal axons of motor neurons (Fig. 8 C)
The formation of IF inclusions in motor neurons has
been associated with motor dysfunction in three other
types of transgenic mice (Côté et al., 1993; Xu et al., 1993;
Lee et al., 1994). However, the properties of IF inclusions
described here differ in several aspects from those of IF in-
clusions observed in mice overexpressing NF transgenes.
Whereas large perikaryal NF accumulations excluding
other cytoplasmic material were observed in the NF-H
and NF-L transgenic mice (Côté et al., 1993; Xu et al.,
1993), the inclusion bodies found in peripherin transgenic
mice are relatively small, they contain membranous mate-
rial including mitochondria and they occur in both cell
bodies and axons. Because of their size and axonal local-
ization, the inclusions observed in peripherin transgenic
mice are more similar to the IF inclusions found in human
ALS (reviewed in Chou, 1995) and in mutant SOD1 trans-
genic mice than are the NF swellings observed in the NF
transgenic mice. More importantly, unlike mice overex-
pressing wild-type NF proteins (Côté et al., 1993; Xu et al.,
1993; our unpublished observation), the mice with periph-
erin inclusions exhibited axonal degeneration and massive
death of motor neurons.
Unexpectedly, the results shown here demonstrate that
the presence of NF-L is not required for the formation of
IF inclusions in motor neurons. This is an important find-
ing because an involvement for NF proteins in ALS has
been recently challenged by studies with L2/2 mice and
NF-H/lacZ mice showing that the absence of intact NFs in
axons did not prevent SOD1-mediated disease (William-
son et al., 1998; Eyer et al., 1998). This led to the belief
that IF proteins play a minor role in ALS pathogenesis, a
notion that must be reexamined at the light of our results
showing that disorganized IF structures containing high
molecular weight NF proteins together with peripherin
can provoke motor neuron death in absence of NF-L.
The exact mechanism underlying cell death by such IF
inclusion bodies remains to be elucidated. A block of in-
tracellular transport by multiple IF inclusions in the axon
is a possible mechanism that may contribute to neurode-
generation and perhaps cell death in the peripherin trans-
genic mice described here. Alternatively, the peripherin-
containing inclusions could provoke neurodegeneration
by the sequestration of organelles such as mitochondria
(Fig. 8) or other components essential for cell survival.
Such a mechanism has been postulated to explain the tox-
icity of SOD1 aggregates detected in SOD1 mutant mice
(Bruijn et al., 1998). In fact, there is growing evidence for
protein aggregation as a common etiology in neurode-
generative disorders including ALS, Alzheimer’s disease,
prion disease, Parkinson’s disease, and a class of disorders
caused by expanded CAG repeats encoding polyglu-
tamines (for review see Kakizuka, 1997). The general
working hypothesis is that mutations in proteins may re-
sult in misfolding and decreased protein degradation, lead-
ing to disturbance in homeostatic mechanisms. For in-
stance, an upregulation of proteins with chaperoning
activity was found to protect against aggregation of mu-
tant ataxin-1 (Cummings et al., 1998) and also from the
toxicity of SOD1 mutants (Bruening et al., 1998). Re-
cently, polyglutamine domain proteins derived from ex-
panded CAG repeats were found to bind specifically to
NF-L and to alter NF network (Nagai et al., 1999). The
data presented here introduces a novel concept in that no
mutant proteins are required for the development of inclu-
sion bodies. In future studies it would be of interest to in-
vestigate whether peripherin inclusions can also be de-
rived by posttranslational modifications of IF proteins. It
is well documented that changes in phosphorylation can
alter the assembly properties of NF proteins (for review
see Julien and Mushynski, 1998). In addition, the nitration
of tyrosine residues in the NF-L protein, a phenomenon
that may occur in ALS (Crow et al., 1997), could impair its
assembly and perhaps would favor interactions of periph-
erin with the high-molecular mass NF subunits to form
noxious IF inclusions.
In conclusion, our study demonstrates for the first time
that an upregulation of wild-type peripherin can cause the
selective death of motor neurons during aging and that a
NF-L deficiency is a factor that precipitates the disease.
These results combined with the specific detection of pe-
ripherin inclusions in motor neurons of sporadic ALS
cases (Corbo and Hays, 1992; Migheli et al., 1993; Tu et al.,
1996) and in motor neuron neurons of presymptomatic
SOD1G37R mice (Fig. 9) provide compelling evidence for a
potential role of peripherin in ALS pathogenesis.
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